Weijia Wang
- Topics
- Cancer-related molecular mechanisms research (7 papers)RNA modifications and cancer (5 papers)Advanced biosensing and bioanalysis techniques (4 papers)
- Cited by
- Cancer ResearchNephrologyImmunology
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Weijia Wang
33 papers receiving 828 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 612
- Immunology 197
- Cancer Research 187
- Oncology 118
- Pulmonary and Respiratory Medicine 83
Countries citing papers authored by Weijia Wang
This map shows the geographic impact of Weijia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Wang more than expected).
Fields of papers citing papers by Weijia Wang
This network shows the impact of papers produced by Weijia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Wang. The network helps show where Weijia Wang may publish in the future.
Co-authorship network of co-authors of Weijia Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Weijia Wang. A scholar is included among the top collaborators of Weijia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijia Wang. Weijia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 70 | |
| 7 | 3 | |
| 8 | 6 | |
| 9 | 10 | |
| 10 | The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8breakdown → | 270 |
| 11 | 7 | |
| 12 | 28 | |
| 13 | 18 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | 8 | |
| 17 | 3 | |
| 18 | 79 | |
| 19 | 28 | |
| 20 | 3 |
About Weijia Wang
Weijia Wang is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 33 papers that have together received 833 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Cancer Research (187 citations), Nephrology (74 citations) and Immunology (197 citations). Weijia Wang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Hang‐zi Chen, Qiao Wu, Yuan-li Ai, Bo Zhou, Zhi‐Hong Jiang, Fu-Nan Li, Dawang Zhou, Kang Cheng, Yuanyuan Lei and Chunliang Wang. Their work appears in journals such as Nature Medicine, Analytical Chemistry and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.